Volume | 201,415 |
|
|||||
News | - | ||||||
Day High | 212.495 | Low High |
|||||
Day Low | 209.74 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Teleflex Inc | TFX | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
210.60 | 209.74 | 212.495 | 211.17 | 211.11 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
7,078 | 201,415 | $ 211.46 | $ 42,592,122 | - | 177.633 - 276.43 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 32,646 | $ 211.17 | USD |
Teleflex Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
9.93B | 47.06M | - | 2.98B | 356.33M | 7.57 | 27.88 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Teleflex News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TFX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 210.67 | 212.56 | 205.26 | 208.00 | 271,038 | 0.50 | 0.24% |
1 Month | 218.25 | 227.65 | 205.26 | 214.90 | 264,968 | -7.08 | -3.24% |
3 Months | 247.06 | 256.85 | 205.26 | 226.45 | 277,040 | -35.89 | -14.53% |
6 Months | 187.49 | 257.85 | 177.633 | 225.75 | 275,190 | 23.68 | 12.63% |
1 Year | 270.28 | 276.43 | 177.633 | 228.46 | 281,438 | -59.11 | -21.87% |
3 Years | 444.59 | 449.375 | 177.633 | 275.85 | 328,717 | -233.42 | -52.50% |
5 Years | 277.99 | 449.375 | 177.633 | 300.92 | 293,935 | -66.82 | -24.04% |
Teleflex Description
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (25% of 2021 sales), interventional (15%), anesthesia (14%), surgical (13%), interventional urology (12%), original-equipment manufacturing (9%), and all other (12%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder. |